Status:

COMPLETED

Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.

Lead Sponsor:

Radius Health, Inc.

Collaborating Sponsors:

Medpace, Inc.

Conditions:

Healthy Volunteers

Eligibility:

All Genders

40-65 years

Phase:

PHASE1

Brief Summary

A study to evaluate and compare the PK profiles of abaloparatide-SC 80 μg and abaloparatide-sMTS 300 μg in a cohort of healthy men and to make a similar evaluation in a cohort of healthy women

Detailed Description

This study aims to evaluate and compare the pharmacokinetic (PK) profiles of abaloparatide-SC 80 μg injected subcutaneously into the periumbilical region of the abdomen, and abaloparatide-sMTS 300 μg ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Male and female subjects aged 40 to 65 years old, inclusive, at Screening;
  • Good general health as determined by medical history and physical exam (including vital signs, and has a body mass index between 18 and 32 kg/m\^2;
  • Laboratory test results within the normal range
  • Serum 25-hydroxyvitamin D values must be \> 20 ng/mL.
  • Exclusion Criteria:
  • Presence or history of any disorder that may prevent the successful completion of the study;
  • Diagnosed with osteoporosis, Paget's disease, or other metabolic bone diseases (eg, vitamin D deficiency or osteomalacia), or had a non-traumatic fracture within 1 year prior to the initial screening;
  • History of any cancer within the past 5 years other than squamous or basal cell carcinoma;
  • History of allergy to abaloparatide or drugs in a similar pharmacological class;.

Exclusion

    Key Trial Info

    Start Date :

    November 16 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 19 2021

    Estimated Enrollment :

    52 Patients enrolled

    Trial Details

    Trial ID

    NCT04663464

    Start Date

    November 16 2020

    End Date

    November 19 2021

    Last Update

    January 6 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Medpace Clinical Pharmacology

    Cincinnati, Ohio, United States, 45227